The burden of pneumococcal pneumonia - Experience of the german competence network CAPNETZ

Pneumologie

Volumn 66, Issue 8, 2012, Pages 470-475

  Pletz, M W ^a   Von Baum, H ^c   Van Der Linden, M ^d   Rohde, G ^e   Schutte H ^f   Suttorp, N ^f   Welte, T ^b  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; SODIUM; UREA;

ADULT; ARTICLE; ASSISTED VENTILATION; BACTERIUM IDENTIFICATION; BODY MASS; BRAIN DISEASE; CIGARETTE SMOKING; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONFUSION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DYSPNEA; FEMALE; FEVER; GERMANY; GLUCOSE BLOOD LEVEL; HEART DISEASE; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; LEUKOCYTE COUNT; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NURSING HOME PATIENT; OXYGEN THERAPY; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT DISEASE; SODIUM BLOOD LEVEL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SUPPURATION; SURVIVAL RATE; THORAX PAIN; UREA NITROGEN BLOOD LEVEL; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COMMUNITY NETWORKS; COMMUNITY-ACQUIRED INFECTIONS; COST OF ILLNESS; FEMALE; GERMANY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PREVALENCE; SICKNESS IMPACT PROFILE; YOUNG ADULT;

EID: 84864672283     PISSN: 09348387     EISSN: 14388790     Source Type: Journal    
DOI: 10.1055/s-0032-1310103     Document Type: Article

References (20)

1. Trotter CL, Stuart JM, George R et al. Increasing hospital admissions for pneumonia, England. Emerg Infect Dis: 2008; 14 727 733 (Pubitemid 351838635)
2. Welte T, Kohnlein T. Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network. Semin Respir Crit Care Med: 2009; 30 127 135
3. Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J Suppl: 2002; 36 20s 27s (Pubitemid 34774185)
4. Marchese A, Esposito S, Coppo E et al. Detection of Streptococcus pneumoniae and identification of pneumococcal serotypes by real-time polymerase chain reaction using blood samples from Italian children 5 years of age with community-acquired pneumonia. Microb Drug Resist: 2011; 17 419 421
5. Pletz MW, Welte T, Ott SR. Advances in the prevention, management, and treatment of community-acquired pneumonia. F1000 Medicine Reports. [Review]: 2010; 2 53
6. Feikin DR, Schuchat A, Kolczak M et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995 1997. Am J Public Health: 2000; 90 223 229 (Pubitemid 30062674)
7. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med: 1964; 60 759 776
8. Fine MJ, Smith MA, Carson CA et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA: 1996; 275 134 141
9. Schweiger B, Zadow I, Heckler R et al. Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples. J Clin Microbiol: 2000; 38 1552 1558 (Pubitemid 30216688)
10. Ewig S, Torres A. Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality. Eur Respir J: 2011; 38 253 260
11. Welte T. Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality. Eur J Clin Microbiol Infect Dis
12. Polverino E, Dambrava P, Cilloniz C et al. Nursing home-acquired pneumonia: a 10 year single-centre experience. Thorax: 2010; 65 354 359
13. Johnstone J, Eurich DT, Minhas JK et al. Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia. Clin Infect Dis: 2010; 51 15 22
14. Moberley SA, Holden J, Tatham DP et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev: 2008; 01 CD000422
15. Johnstone J. ACP Journal Club. Review: pneumococcal vaccination is not effective for preventing pneumonia, bacteremia, bronchitis, or mortality. Ann Intern Med: 2009; 150 5 14
16. Huss A, Scott P, Stuck AE et al. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ: 2009; 180 48 58
17. Maruyama T, Taguchi O, Niederman MS et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ: 2010; 340 1004
18. von Baum H, Welte T, Marre R et al. Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ). BMC Infect Dis: 2009; 9 62
19. Ruiz-Gonzalez A, Falguera M, Nogues A et al. Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia. Am J Med: 1999; 106 385 390 (Pubitemid 29190589)
20. Ishida T, Hashimoto T, Arita M et al. Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest: 1998; 114 1588 1593 (Pubitemid 128487480)